Inox Clean Energy has agreed to buy Boviet Solar’s US solar manufacturing assets for $750 million, including module and cell production units in North Carolina. The acquisition is designed to give Inox Clean a stronger foothold in the expanding US solar market and accelerate its manufacturing and supply capabilities as demand grows.
The Nasdaq 100 tumbled more than 2% in Tuesday trading, extending its sharpest sell-off in weeks as April CPI confirmed inflation is no longer cooling. The rise pushed CPI to its highest level since May 2023, rattling investors and weighing on the Dow and S&P 500. Traders now face growing uncertainty over rates and market direction.
Your news, in seconds
Get the Beige app — every story in 60 words, updated hourly. Free on iOS & Android.
Waaree Energies is looking to expand aggressively in the United States, with plans that may include building a solar cell manufacturing facility. The move comes after the company increased its solar module manufacturing capacity. Waaree wants to gain market share in the growing US solar sector while also continuing to build an energy transition ecosystem in India.
Novo Nordisk is relaunching a diabetes tablet in the United States under the Ozempic name, starting with select adult doses this Monday. The strategy banks on Ozempic’s blockbuster brand recognition to lift sales and help Novo regain market share from rival Eli Lilly as competition intensifies in diabetes care.
Meta Platforms has sharply lifted its capital spending outlook, signaling a heavier investment push into artificial intelligence. The move lands amid intensifying regulatory scrutiny and mounting user backlash, particularly over concerns that social media platforms are harming or influencing younger users. The company’s aggressive AI bets are now colliding with both policy pressure and growing public frustration.
Inox Clean Energy is set to acquire US-based Boviet Solar in a deal valued around $750 million, aiming to accelerate its entry and expansion in the American solar market. Boviet Solar is described as a major player among US solar equipment makers, making the acquisition a potential shortcut to scale and market presence rather than building from scratch.
Never miss a story
Set alerts for the topics and sources you care about. Download Beige for free.
Indian pharma’s US outlook has improved after years of pressure from price erosion and compliance hurdles. Drug shortages have temporarily slowed price erosion, while launches of key generic drugs have helped companies regain footing. Yet the real question is sustainability: will the same conditions hold, or will competition and supply normalization bring renewed margin stress?
A McKinsey report says India has become a major smartphone supplier to the United States, covering about 40% of demand that China previously met. The shift highlights how supply chains are being redrawn, with Indian production playing an outsized role in meeting US handset needs. The development could reshape bargaining power for global mobile brands.
Swipe through stories, personalise your feed, and save articles for later — all on the app.